Home › Funds › GRIMES & Co WEALTH MANAGEMENT, LLC › GILD

GRIMES & Co WEALTH MANAGEMENT, LLC position in GILD

GILEAD SCIENCES INC · Health Care

GRIMES & Co WEALTH MANAGEMENT, LLC reported holding 135,054 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$20.1M, representing 0.47% of its reported portfolio and ranking #45 among its reported holdings. GRIMES & Co WEALTH MANAGEMENT, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)135.05K sh
Reported value held$20.13M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GRIMES & Co WEALTH MANAGEMENT, LLC's GILD position evolved

GRIMES & Co WEALTH MANAGEMENT, LLC first disclosed a stake in GILD in Q3 2023 at 16,945 shares (US$1.3M). The position peaked in Q1 2026 at 148,679 shares, worth US$20.7M. Across 13 filings, GRIMES & Co WEALTH MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 135,054 shares valued at US$20.1M — a reduction of -2,909 shares quarter over quarter.. Notable position changes include a 1003% increase in Q2 2024 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.95K $1.27M New
Q4 2023 17.04K $1.38M Add
Q1 2024 17.41K $1.27M Add
Q2 2024 192.03K $13.18M Add
Q3 2024 177.89K $14.91M Reduce
Q4 2024 179.43K $16.57M Add
Q1 2025 163.62K $18.33M Reduce
Q2 2025 157.27K $17.44M Reduce
Q3 2025 160.15K $17.78M Add
Q4 2025 150.37K $18.46M Reduce
Q1 2026 148.68K $20.72M Reduce
Q2 2026 137.96K $17.43M Reduce
Q3 2026 135.05K $20.13M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has GRIMES & Co WEALTH MANAGEMENT, LLC held GILD?

GRIMES & Co WEALTH MANAGEMENT, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GRIMES & Co WEALTH MANAGEMENT, LLC's current position in GILD?

As of Q3 2026, GRIMES & Co WEALTH MANAGEMENT, LLC holds 135.05K shares of GILD (GILEAD SCIENCES INC), valued at $20.13M, representing 0.47% of its reported portfolio and ranking #45.

Has GRIMES & Co WEALTH MANAGEMENT, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), GRIMES & Co WEALTH MANAGEMENT, LLC reduced its position in GILD. The position peaked in Q1 2026 at 148.68K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.